Medicines Co. (MDCO), Alnylam (ALNY) Announces Positive Final Results from ORION-1 Phase II Study of Inclisiran
March 17, 2017 12:16 PM
The Medicines Company (NASDAQ: MDCO) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced positive final results from the ORION-1 Phase ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
